Please use this identifier to cite or link to this item:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

AuthorsJesús Maestre, Silvia; Labrador, Miguel Ángel; Adarmes Gómez, A. D.; Méndel-Del Barrio, C.; Martínez-Castrillo, J. C.; Alonso Cánovas, Araceli; Sánchez Alonso, P.; Novo Ponte, S.; Alonso Losada, G.; López-Ariztegui, Nuria; Segundo Rodríguez, J. C.; Morales Casado, M. I.; Gastón, I.; Lacruz, F.; Clavero, P.; Kulisevsky, Jaime; Pagonabarraga-Mora, Javier; Pascual-Sedano, B.; Martínez Martín, Pablo; Santos-García, Diego; Mir, Pablo CSIC ORCID
Issue Date9-Oct-2020
PublisherSpringer Nature
CitationScientific Reports 10: 16893 (2020)
AbstractThe study was aimed at analysing the frequency of impulse control disorders (ICDs) and compulsive behaviours (CBs) in patients with Parkinson’s disease (PD) and in control subjects (CS) as well as the relationship between ICDs/CBs and motor, nonmotor features and dopaminergic treatment in PD patients. Data came from COPPADIS-2015, an observational, descriptive, nationwide (Spain) study. We used the validated Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) for ICD/CB screening. The association between demographic data and ICDs/CBs was analyzed in both groups. In PD, this relationship was evaluated using clinical features and treatment-related data. As result, 613 PD patients (mean age 62.47 ± 9.09 years, 59.87% men) and 179 CS (mean age 60.84 ± 8.33 years, 47.48% men) were included. ICDs and CBs were more frequent in PD (ICDs 12.7% vs. 1.6%, p < 0.001; CBs 7.18% vs. 1.67%, p = 0.01). PD patients had more frequent previous ICDs history, premorbid impulsive personality and antidepressant treatment (p < 0.05) compared with CS. In PD, patients with ICDs/CBs presented younger age at disease onset, more frequent history of previous ICDs and premorbid personality (p < 0.05), as well as higher comorbidity with nonmotor symptoms, including depression and poor quality of life. Treatment with dopamine agonists increased the risk of ICDs/CBs, being dose dependent (p < 0.05). As conclusions, ICDs and CBs were more frequent in patients with PD than in CS. More nonmotor symptoms were present in patients with PD who had ICDs/CBs compared with those without. Dopamine agonists have a prominent effect on ICDs/CBs, which could be influenced by dose.
DescriptionCOPPADIS Study Group.
Publisher version (URL)
Identifiersdoi: 10.1038/s41598-020-73756-z
e-issn: 2045-2322
Appears in Collections:(IBIS) Artículos

Files in This Item:
File Description SizeFormat
coppADiS_cohort.pdf1,37 MBAdobe PDFThumbnail
Show full item record
Review this work

Page view(s)

checked on Jan 22, 2022


checked on Jan 22, 2022

Google ScholarTM


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.